Skip to Content

'
Richard L. Theriault

Present Title & Affiliation

Primary Appointment

Professor, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Research Interests

Pregnancy and breast cancer.

Diagnosis and management of bone metastasis.

Cancer care guidelines.

Health service research and outcomes analyses.

Clinical Interests

Care for patients in the outpatient setting.

Education & Training

Degree-Granting Education

1998 The University of Houston, Houston, TX, MBA, Business Administration
1973 Kirksville College of Osteopathic Medicine, Kirksville, MO, DO, Osteopathic Medicine
1970 Truman State University, Kirksville, MO, BS, B.S.

Postgraduate Training

7/1983-6/1985 Fellow, Medical Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, TX, Dr. Gabriel N. Hortobagyi
7/1976-6/1977 Residency, Internal Medicine, Oklahoma Osteopathic Hospital, Tulsa, OK, Dr. Richard C. Stabb
7/1974-6/1976 Residency, Internal Medicine, Normandy Osteopathic Hospital, St. Louis, MO, Dr. Thomas J. Stees
7/1973-6/1974 Rotating Internship, Normandy Osteopathic Hospital, St. Louis, MO, Dr. Robert Owen

Board Certifications

1986 American Osteopathic Board of Internal Medicine - Oncology
1980 American Osteopathic Board of Internal Medicine - Internal Medicine

Experience/Service

Institutional Committee Activities

Chairman, Institutional Review Board 2, 2003

Selected Publications

Peer-Reviewed Original Research Articles
1. Dominici L, Kuerer H, Babiera G, Hahn K, Perkins G, Middleton L, Ramirez M, Yang W, Hortobagyi G, Theriault RL, Litton JK. Wound complications from surgery in pregnancy-associated breast cancer (PABC). Am J Surg. In Press.
2. Hassett MJ, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC. Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer. J Clin Oncol. e-Pub 10/2008. PMID: 18955448.
3. Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, Carlson RW, Theriault RL, Weeks JC. Selecting high priority quality measures for breast cancer quality improvement. Med Care 46(8):762-70, 8/2008. PMID: 18665055.
4. Punglia RS, Hughes ME, Edge SB, Theriault RL, Bookman MA, Wilson JL, Ottesen RA, Niland JC, Weeks JC. Factors Associated with Guideline-Concordant Use of Radiotherapy After Mastectomy in the National Comprehensive Cancer Network. Int J Radiat Oncol Biol Phys 72(5):1434-1440, 2008. e-Pub 5/2008. PMID: 18472360.
5. Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Theriault RL, Weeks JC. Impact of Randomized Clinical Trial Results on the Use of Tamoxifen Following Breast Surgery for Ductal Carcinoma in Situ in the National Comprehensive Network. J Clin Oncol. 22:3251-8, 8/2007.
6. Carlson RW, Anderson BO, Burstein HJ, Carter WB, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Ljung BM, Kiel K, Marks LB, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, Winer EP, Wolff AC. Invasive Breast Cancer. J Natl Compr Canc Netw 3(3):246-312, 3/2007. PMID: 17439758.
7. Theriault R, Hahn K. Management of Breast Cancer in Pregnancy. Curr Oncol Rep 9:17-21, 1/2007.
8. Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, Yang W, Perkins G, Hortobagyi GN, Theriault RL. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107(6):1219-26, 9/2006. PMID: 16894524.
9. Morrow PK, Theriault RL. Pregnancy after the diagnosis of breast cancer. Clin Breast Cancer 7(2):173-5, 6/2006. PMID: 16800981.
10. Yang WT, Dryden MJ, Gwyn K, Whitman GJ, Theriault R. Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy. Radiology 239:52-60, 4/2006. PMID: 16484353.
11. Christian CK, Niland J, Edge SB, Ottesen RA, Hughes ME, Theriault R, Wilson J, Hergrueter CA, Weeks JC. A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg 243:241-9, 2/2006. PMID: 16432358.
12. Loibl S, von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, Keller M, Harder S, Theriault RL, Crivellari D, Klingebiel T, Louwen F, Kaufmann M. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 106(2):237-46, 1/2006. PMID: 16342247.
13. Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, Bookman MA, Weeks JC. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol 24(3):361-9, 1/2006. PMID: 16421417.
14. Fanale MA, Uyei AR, Theriault RL, Adam K, Thompson RA. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer 6(4):354-6, 10/2005. PMID: 16277887.
15. Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML. Breast cancer treatment guidelines in older women. J Clin Oncol 23:783-91, 2/2005. PMID: 15681522.
16. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema DF, Feuer EJ, Theriault RL. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784-1792, 2005.
17. Carlson RW, Anderson BO, Burstein HJ, Cox CE, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis C, Jahanzeb M, Ljung B-M, Marks LB, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, Winer EP, Wolff AC. The NCCN Breast Cancer Clinical Practice Guidelines in Oncology. J Natl Comp Cancer Network 3:238-289, 2005.
18. Gonzalez-Angulo AM, Walters RS, Carpenter RJ, Jr, Ross MI, Perkins GH, Gwyn K, Theriault RL. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer 5:317-9, 10/2004. PMID: 15507181.
19. Edge SB, Niland JC, Bookman MA, Theriault RL, Ottesen R, Lepisto E, Weeks JC. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst 95:1514-21, 10/2003. PMID: 14559873.
20. Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 98:1055-60, 9/2003. PMID: 12942575.
21. Theriault RL. Zoledronic acid (Zometa) use in bone disease. Expert Rev Anticancer Ther 3:157-66, 4/2003. PMID: 12722875.
22. Kuerer HM, Gwyn K, Ames FC, Theriault RL. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery 131(1):108-10, 2002. PMID: 11812971.
23. Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, Ames FC, Buchholz TA, Sahin AA, Kuerer HM. Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg 194(1):54-64, 2002. PMID: 11800340.
24. Lipton A, Theriault RL, Hortobagyi GN, Simeone J, Knight RD, Mellars K, Reitsma DJ, Heffernan M, Seaman JJ. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases. Long term follow-up of two randomized, placebo-controlled trials. Cancer 88:1082-90, 3/2000. PMID: 10699899.
25. Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, Buzdar AU, Hortobagyi GN. Multidisciplinary management of breast cancer during pregnancy: An 8 year experience using a standardized protocol. J Clin Oncol 17:855-61, 3/1999. PMID: 10071276.
26. Theriault RL, Lipton A, Hortobagyi GN, Leff R, Gluck S, Stewart JF, Costello S, Kennedy I, Simeone J, Seaman JJ, Knight RD, Mellars K, Heffernan M, Reitsma DJ. Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. J Clin Oncol 17:846-54, 3/1999. PMID: 10071275.
27. Lipton A, Demers L, Curley E, Chinchilli V, Gaydos L, Hortobagyi G, Theriault R, Clemens D, Costa L, Seaman J, Knight R. Markers of bone resorption in patients treated with pamidronate. Eur J Cancer 34(13):2021-6, 12/1998. PMID: 10070304.
28. Hortobagyi GN, Theriault RL, Lipton A, Porter L, Blayney D, Sinoff C, Wheeler H, Simeone JF, Seaman JJ, Knight RD, Heffernan M, Mellars K, Reitsma DJ. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. J Clin Oncol 16(6):2038-44, 6/1998. PMID: 9626201.
29. Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, Sinoff C, Wheeler H, Simeone JF, Seaman J, Knight RD. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. N Engl J Med 335(24):1785-91, 12/1996. PMID: 8965890.

Invited Articles
1. Theriault RL. Strategies to prevent chemotherapy-induced bone loss in women with breast cancer. Clin Breast Cancer 5 Suppl:S63-70, 2/2005. PMID: 15807926.

Last updated: 9/1/2009